bisindolylmaleimide i has been researched along with T-Cell Lymphoma in 2 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tamir, A | 1 |
| Granot, Y | 1 |
| Isakov, N | 1 |
| Cremaschi, GA | 1 |
| Genaro, AM | 1 |
| Cazaux, CA | 1 |
| Anesini, C | 1 |
| Wald, M | 1 |
| Borda, T | 1 |
| Sterin-Borda, L | 1 |
2 other studies available for bisindolylmaleimide i and T-Cell Lymphoma
| Article | Year |
|---|---|
Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Bucladesine; Calcium-Calmodulin-Dependent Protein K | 1996 |
Altered beta-adrenoceptor function associated to protein kinase C activation in hyperproliferative T lymphocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenylyl Cyclases; Adrenergic beta-Agonists; Cell Div | 2000 |